Emerging insights into the ependymoma epigenome
Ependymoma is the third most common pediatric brain tumor, yet because of the paucity of effective therapeutic interventions, 45% of patients remain incurable. Recent transcriptional and copy number profiling of the disease has identified few driver genes and in fact points to a balanced genomic pro...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 February 2013
|
| In: |
Brain pathology
Year: 2013, Jahrgang: 23, Heft: 2, Pages: 206-209 |
| ISSN: | 1750-3639 |
| DOI: | 10.1111/bpa.12020 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/bpa.12020 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bpa.12020 
|
| Verfasserangaben: | Stephen C. Mack, Hendrik Witt, Xin Wang, Till Milde, Yuan Yao, Kelsey C. Bertrand, Andrey Korshunov, Stefan M. Pfister, Michael D. Taylor |
| Zusammenfassung: | Ependymoma is the third most common pediatric brain tumor, yet because of the paucity of effective therapeutic interventions, 45% of patients remain incurable. Recent transcriptional and copy number profiling of the disease has identified few driver genes and in fact points to a balanced genomic profile. Candidate gene approaches looking at hypermethylated promoters and genome-wide epigenetic arrays suggest that DNA methylation may be critical to ependymoma pathogenesis. This review attempts to highlight existing and emerging evidence implicating the ependymoma epigenome as a key player and that epigenetic modifiers may offer new targeted therapeutic avenues for patients. |
|---|---|
| Beschreibung: | Gesehen am 11.06.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1750-3639 |
| DOI: | 10.1111/bpa.12020 |